Mark Halvorson

Array ( [id] => 10083521 [patent_doc_number] => 09120860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Protein involved in ovarian cancer' [patent_app_type] => utility [patent_app_number] => 13/566011 [patent_app_country] => US [patent_app_date] => 2012-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 16484 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13566011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9774830 [patent_doc_number] => 20140298493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'PIK3CA H1047R Knock-In Non-Human Animal Breast Cancer Model' [patent_app_type] => utility [patent_app_number] => 14/233976 [patent_app_country] => US [patent_app_date] => 2012-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14488 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11191557 [patent_doc_number] => 09422358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'Plexin D1 as a target for tumor diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 13/541296 [patent_app_country] => US [patent_app_date] => 2012-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13541296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9569863 [patent_doc_number] => 20140187577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/122339 [patent_app_country] => US [patent_app_date] => 2012-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31336 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8522207 [patent_doc_number] => 20120321615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'Assay for Metastatic Colorectal Cancer' [patent_app_type] => utility [patent_app_number] => 13/481629 [patent_app_country] => US [patent_app_date] => 2012-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9267 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13481629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416576 [patent_doc_number] => 20120244076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'csPCNA Isoform Antibodies And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/477419 [patent_app_country] => US [patent_app_date] => 2012-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16169 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10026112 [patent_doc_number] => 09068000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I' [patent_app_type] => utility [patent_app_number] => 13/474294 [patent_app_country] => US [patent_app_date] => 2012-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21716 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13474294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9806280 [patent_doc_number] => 20150018225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'CELL ADHESION INHIBITOR, CELL PROLIFERATION INHIBITOR, AND METHOD AND KIT FOR EXAMINING CANCER' [patent_app_type] => utility [patent_app_number] => 14/117585 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 42493 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441846 [patent_doc_number] => 20120258462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'COMBINATIONS OF TUMOR-ASSOCIATED ANTIGENS IN DIAGNOSTICS FOR VARIOUS TYPES OF CANCERS' [patent_app_type] => utility [patent_app_number] => 13/453903 [patent_app_country] => US [patent_app_date] => 2012-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20812 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335530 [patent_doc_number] => 20120202208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 193P1E1B USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/450405 [patent_app_country] => US [patent_app_date] => 2012-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 115760 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382167 [patent_doc_number] => 20120225794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Antibodies Specific to Heterodimers of Bcl-2 Family and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/428889 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6267 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10104928 [patent_doc_number] => 09140705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Tumor suppressor killin' [patent_app_type] => utility [patent_app_number] => 13/427295 [patent_app_country] => US [patent_app_date] => 2012-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 24 [patent_no_of_words] => 43453 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13427295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323424 [patent_doc_number] => 20120195830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'Monoclonal Antibodies Against Claudin-18 For Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 13/425538 [patent_app_country] => US [patent_app_date] => 2012-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 39467 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335504 [patent_doc_number] => 20120202207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA' [patent_app_type] => utility [patent_app_number] => 13/412696 [patent_app_country] => US [patent_app_date] => 2012-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 132 [patent_figures_cnt] => 132 [patent_no_of_words] => 20946 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9009353 [patent_doc_number] => 08524651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Method of therapy' [patent_app_type] => utility [patent_app_number] => 13/396254 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17219 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476639 [patent_doc_number] => 20120276045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'TREATMENT OF SOLID CANCERS' [patent_app_type] => utility [patent_app_number] => 13/360914 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15832 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477701 [patent_doc_number] => 20120277109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'PROXIMITY-MEDIATED ASSAYS FOR DETECTING ONCOGENIC FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/361881 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 48012 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13361881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8966300 [patent_doc_number] => RE044437 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2013-08-13 [patent_title] => 'Methods for detecting receptor complexes comprising PI3K' [patent_app_type] => reissue [patent_app_number] => 13/352705 [patent_app_country] => US [patent_app_date] => 2012-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 55 [patent_no_of_words] => 26542 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192018 [patent_doc_number] => 20130331333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'PAR1 AND PAR2 C-TAIL PEPTIDES AND PEPTIDE MIMETICS' [patent_app_type] => utility [patent_app_number] => 13/977545 [patent_app_country] => US [patent_app_date] => 2011-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17576 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239872 [patent_doc_number] => 20120148613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'MULTIVALENT ENTRAIN-AND-AMPLIFY IMMUNOTHERAPEUTICS FOR CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/336523 [patent_app_country] => US [patent_app_date] => 2011-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19679 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13336523 [rel_patent_id] =>[rel_patent_doc_number] =>)